Efficient numerical Fresnel diffraction with Gabor frames
Photonics Research · 01.02.2025 · 13 (2) · 330
DOI: 10.1364/prj.530818 ↗Kurz gefasst
Fachartikel in der Zeitschrift Photonics Research, online erschienen am 17.01.2025. Verfasst von David Blinder und 2 weiteren Autor:innen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Fonds Wetenschappelijk Onderzoek, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Numerical Fresnel diffraction is broadly used in optics and holography in particular. So far, it has been implemented using convolutional approaches, spatial convolutions, or the fast Fourier transform. We propose a new way, to our knowledge, of computing Fresnel diffraction using Gabor frames and chirplets. Contrary to previous techniques, the algorithm has linear-time complexity, does not exhibit aliasing, does not need zero padding, has no constraints on changing shift/resolution/pixel pitch between source and destination planes, and works at any propagation distance. We provide theoretical and numerical analyses, detail the algorithm, and report simulation results with an accelerated GPU implementation. This algorithm may serve as a basis for more flexible, faster, and memory-efficient computer-generated holography methods.
Förderung
- Fonds Wetenschappelijk Onderzoek
- Japan Society for the Promotion of Science
Zitieren
APA
Blinder, D., Birnbaum, T., & Schelkens, P. (2025). Efficient numerical Fresnel diffraction with Gabor frames. Photonics Research, 13(2), 330. https://doi.org/10.1364/prj.530818
Vancouver
Blinder D, Birnbaum T, Schelkens P. Efficient numerical Fresnel diffraction with Gabor frames. Photonics Research. 2025;13(2):330. doi:10.1364/prj.530818
BibTeX
@article{Blinder2025,
author = {Blinder, David and Birnbaum, Tobias and Schelkens, Peter},
title = {Efficient numerical Fresnel diffraction with Gabor frames},
journal = {Photonics Research},
year = {2025},
volume = {13},
number = {2},
pages = {330},
doi = {10.1364/prj.530818}
}
EUVIMED